Please login to the form below

Not currently logged in
Email:
Password:

PureTech appoints Joseph Bolen as entrepreneur-in-residence

And Vincent Hennemand joins as VP, company development and operations

PureTech Health Joseph BolenBoston-based PureTech Health has appointed Joseph Bolen (pictured) as entrepreneur-in-residence.

He previously served as president of research and development at Moderna Therapeutics and as chief scientific officer at Millennium Pharmaceuticals.

Prior to joining Millennium in 1999, Dr. Bolen held senior R&D positions at Hoechst Marion Roussel, Schering-Plough, and Bristol-Myers Squibb.

As PureTech's entrepreneur-in-residence he will work with the firm's company creation team to identify and pursue promising new medicines.

Also joining PureTech, which focuses on developing novel medicines, is Vincent Hennemand.

He was formerly principal in Sanofi's corporate R&D venture group and joins the cross-disciplinary healthcare firm as its vice president of company development and operations.

Prior to that Hennemand was chief of staff to the president of global R&D and the general secretary for the corporate scientific advisory committee (SDSAC), which investigates scientific proposals and projects of potential interest to Sanofi.

9th December 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics